Mirae Asset Global ETFs Holdings’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
+40,050
New +$191K ﹤0.01% 2352
2025
Q2
– Sell
-20,591
Closed -$55K – 3000
2025
Q1
$55K Buy
20,591
+858
+4% +$2.67K ﹤0.01% 2829
2024
Q4
$69.5K Buy
19,733
+836
+4% +$3.79K ﹤0.01% 2831
2024
Q3
$89.6K Buy
+18,897
New +$86.3K ﹤0.01% 2759

Other funds holding ACHV

Mirae Asset Global ETFs Holdings's ACHV Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 40,050 shares worth $260K. The stake represents ﹤0.01% of the portfolio and ranks #2352 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in ACHV as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in ACHV in Q3 2024 and has held it in 4 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 40,050 shares of Achieve Life Sciences worth $260K as of Q2 2026.
  • Achieve Life Sciences was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Achieve Life Sciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2352 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Achieve Life Sciences in Q3 2024 and has held it in 4 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.